Antibody Testing
In vitro diagnostic test developer completes agreement with American distributor
Published in TB and Outbreaks Week, January 7th, 2003
This agreement contemplates the issuance of 150,000 common shares with an additional 2 warrants for each share purchased at an exercise price of $1.50 for a 2-year period. This agreement is subject to applicable securities laws and approval by the TSX Venture Exchange.
AHD is also MedMira's exclusive distributor in the United States, and has previously ordered 500,000 Reveal Rapid HIV-1 Antibody Tests to be delivered following receipt of premarket approval by the United States Food and Drug...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Chlamydia
New team approach dramatically boosts chlamydia screening of teen-age girls - Infectious Disease Therapy
Azithromycin effective against Shiga toxin-producing E. coli - Infectious Disease Therapy
Cryptococcus neoformans protein triggers murine anticandidal activity - Infectious Disease Therapy
Yeast adhesin analogs can prevent intestinal C. albicans infection - Norwalk-like Virus
Inspections sharply reduce diarrhea outbreaks on cruise ships - Tuberculosis Pathogenesis
T helper 2 activity doesn't impair response to infection - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
